These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 11593336

  • 1. Selection of drug-resistant transduced cells with cytosine nucleoside analogs using the human cytidine deaminase gene.
    Beauséjour CM, Eliopoulos N, Momparler L, Le NL, Momparler RL.
    Cancer Gene Ther; 2001 Sep; 8(9):669-76. PubMed ID: 11593336
    [Abstract] [Full Text] [Related]

  • 2. Drug resistance to 5-aza-2'-deoxycytidine, 2',2'-difluorodeoxycytidine, and cytosine arabinoside conferred by retroviral-mediated transfer of human cytidine deaminase cDNA into murine cells.
    Eliopoulos N, Cournoyer D, Momparler RL.
    Cancer Chemother Pharmacol; 1998 Sep; 42(5):373-8. PubMed ID: 9771951
    [Abstract] [Full Text] [Related]

  • 3. Human cytidine deaminase as an ex vivo drug selectable marker in gene-modified primary bone marrow stromal cells.
    Eliopoulos N, Al-Khaldi A, Beauséjour CM, Momparler RL, Momparler LF, Galipeau J.
    Gene Ther; 2002 Apr; 9(7):452-62. PubMed ID: 11938460
    [Abstract] [Full Text] [Related]

  • 4. Retroviral transfer and long-term expression of human cytidine deaminase cDNA in hematopoietic cells following transplantation in mice.
    Eliopoulos N, Bovenzi V, Le NL, Momparler LF, Greenbaum M, Létourneau S, Cournoyer D, Momparler RL.
    Gene Ther; 1998 Nov; 5(11):1545-51. PubMed ID: 9930308
    [Abstract] [Full Text] [Related]

  • 5. Resistance to cytosine arabinoside by retrovirally mediated gene transfer of human cytidine deaminase into murine fibroblast and hematopoietic cells.
    Momparler RL, Eliopoulos N, Bovenzi V, Létourneau S, Greenbaum M, Cournoyer D.
    Cancer Gene Ther; 1996 Nov; 3(5):331-8. PubMed ID: 8894252
    [Abstract] [Full Text] [Related]

  • 6. Coexpression of cytidine deaminase and mutant dihydrofolate reductase by a bicistronic retroviral vector confers resistance to cytosine arabinoside and methotrexate.
    Beauséjour CM, Le NL, Létourneau S, Cournoyer D, Momparler RL.
    Hum Gene Ther; 1998 Nov 20; 9(17):2537-44. PubMed ID: 9853520
    [Abstract] [Full Text] [Related]

  • 7. Coexpression of rat glutathione S-transferase A3 and human cytidine deaminase by a bicistronic retroviral vector confers in vitro resistance to nitrogen mustards and cytosine arabinoside in murine fibroblasts.
    Létourneau S, Palerme JS, Delisle JS, Beauséjour CM, Momparler RL, Cournoyer D.
    Cancer Gene Ther; 2000 May 20; 7(5):757-65. PubMed ID: 10830723
    [Abstract] [Full Text] [Related]

  • 8. Cytotoxic activity of 2',2'-difluorodeoxycytidine, 5-aza-2'-deoxycytidine and cytosine arabinoside in cells transduced with deoxycytidine kinase gene.
    Beauséjour CM, Gagnon J, Primeau M, Momparler RL.
    Biochem Biophys Res Commun; 2002 May 24; 293(5):1478-84. PubMed ID: 12054682
    [Abstract] [Full Text] [Related]

  • 9. [Mice transduced with double-mutant dihydrofolate reductase-cytidine deaminase fusion gene attained protection from high dose chemotherapy].
    Lu P, Lu Y, Pang K, Wang SB, Chen JQ, Xu HM, Wang JK, Zhao SC.
    Zhonghua Wai Ke Za Zhi; 2005 Aug 01; 43(15):998-1001. PubMed ID: 16194358
    [Abstract] [Full Text] [Related]

  • 10. Forced expression of cytidine deaminase confers resistance to cytosine arabinoside and gemcitabine.
    Neff T, Blau CA.
    Exp Hematol; 1996 Sep 01; 24(11):1340-6. PubMed ID: 8862446
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological approach for optimization of the dose schedule of 5-Aza-2'-deoxycytidine (Decitabine) for the therapy of leukemia.
    Momparler RL, Côté S, Eliopoulos N.
    Leukemia; 1997 Mar 01; 11 Suppl 1():S1-6. PubMed ID: 9130684
    [Abstract] [Full Text] [Related]

  • 12. Expression of a novel double-mutant dihydrofolate reductase-cytidine deaminase fusion gene confers resistance to both methotrexate and cytosine arabinoside.
    Sauerbrey A, McPherson JP, Zhao SC, Banerjee D, Bertino JR.
    Hum Gene Ther; 1999 Oct 10; 10(15):2495-504. PubMed ID: 10543614
    [Abstract] [Full Text] [Related]

  • 13. Gene amplification of human cytidine deaminase proviral cDNA and increased levels of its mRNA produces enhanced drug resistance to cytosine arabinoside in retroviral-transduced murine fibroblasts.
    Beauséjour CM, Momparler RL.
    Cancer Lett; 1999 Jan 08; 135(1):29-36. PubMed ID: 10077218
    [Abstract] [Full Text] [Related]

  • 14. Transfection of murine fibroblast cells with human cytidine deaminase cDNA confers resistance to cytosine arabinoside.
    Momparler RL, Laliberté J, Eliopoulos N, Beauséjour C, Cournoyer D.
    Anticancer Drugs; 1996 May 08; 7(3):266-74. PubMed ID: 8791999
    [Abstract] [Full Text] [Related]

  • 15. Chemoprotection of murine hematopoietic cells by combined gene transfer of cytidine deaminase (CDD) and multidrug resistance 1 gene (MDR1).
    Brennig S, Lachmann N, Buchegger T, Hetzel M, Schambach A, Moritz T.
    J Exp Clin Cancer Res; 2015 Dec 12; 34():148. PubMed ID: 26651614
    [Abstract] [Full Text] [Related]

  • 16. Methotrexate selection of long-term culture initiating cells following transduction of CD34(+) cells with a retrovirus containing a mutated human dihydrofolate reductase gene.
    Takebe N, Xu LC, MacKenzie KL, Bertino JR, Moore MA.
    Cancer Gene Ther; 2002 Mar 12; 9(3):308-20. PubMed ID: 11896448
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2'-deoxycytidine.
    Lemaire M, Momparler LF, Raynal NJ, Bernstein ML, Momparler RL.
    Cancer Chemother Pharmacol; 2009 Feb 12; 63(3):411-6. PubMed ID: 18398609
    [Abstract] [Full Text] [Related]

  • 18. Constitutive overexpression of the cytidine deaminase gene confers resistance to cytosine arabinoside in vitro.
    Schröder JK, Kirch C, Flasshove M, Kalweit H, Seidelmann M, Hilger R, Seeber S, Schütte J.
    Leukemia; 1996 Dec 12; 10(12):1919-24. PubMed ID: 8946931
    [Abstract] [Full Text] [Related]

  • 19. Decreased resistance to gemcitabine (2',2'-difluorodeoxycitidine) of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidine kinase.
    Bergman AM, Pinedo HM, Jongsma AP, Brouwer M, Ruiz van Haperen VW, Veerman G, Leyva A, Eriksson S, Peters GJ.
    Biochem Pharmacol; 1999 Feb 15; 57(4):397-406. PubMed ID: 9933028
    [Abstract] [Full Text] [Related]

  • 20. Effect of cytarabine and decitabine in combination in human leukemic cell lines.
    Qin T, Youssef EM, Jelinek J, Chen R, Yang AS, Garcia-Manero G, Issa JP.
    Clin Cancer Res; 2007 Jul 15; 13(14):4225-32. PubMed ID: 17634552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.